Factor V Analysis, Product Factors (RFV Score), Duration of Exposure Riska
| Duration of Patient Exposure | ||||||
|---|---|---|---|---|---|---|
| <14 days | 14 days–1 month | 1–3 months | 3–6 months | 6–12 months | >12 months | |
| Genotoxic and carcinogenic impurity threshold (μg/day) | 120 | 60 | 20 | 10 | 5 | 1.5 |
| Duration of Exposure Risk Factor | 1 | 2 | 3 | 5 | 7 | 10 |
↵a Note: a See reference 44.